SUBSCRIBE
SUBSCRIBE

Asia

Japanese Temporary Tattoos Indicate Allergic Reaction To Buckwheat Soba Noodles By Changing Color
May 19, 2016
 · 
1 min read
Could These Genetically Modified Fish Make Food Safer For Everybody? Vitargent Reveals
May 19, 2016
 · 
1 min read
High Blood Pressure In Middle Age Linked To Dementia, George Institute For Global Health Study
May 19, 2016
 · 
1 min read
This Tremor Tracking Wearable Lets Parkinson’s And ET Patients Take Charge
May 17, 2016
 · 
1 min read
Can Tai Chi Truly Help Those With Knee Arthritis? Published In Annals Of Internal Medicine
May 17, 2016
 · 
1 min read
Biotech Bay
Technology Will Human Beings Live Forever? These Companies Are Betting On It
May 16, 2016
 · 
1 min read
Israeli Medical Company Hopes To Save Thousands Of Women’s Lives Per Year, Illumigyn Reveals
May 16, 2016
 · 
1 min read
Australia’s Starpharma, Ansell To Supply Anti-Zika Condoms For Olympics
May 16, 2016
 · 
2 min read
Bacteria Living On Your Head Might Be Why You Have Dandruff, Shanghai Jiao Tong University Study
May 13, 2016
 · 
1 min read
How to Find Your First Biopharma Job Right Out of College
Biotech Bay
Eli Lilly and Regeneron Tips: How to Find Your First Biopharma Job Right Out of College
May 9, 2016
 · 
8 min read
Load More
PRESS RELEASES
Press Releases
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
January 22, 2026
 · 
3 min read
Press Releases
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe
January 22, 2026
 · 
3 min read
Press Releases
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
January 22, 2026
 · 
10 min read
Press Releases
Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position
January 21, 2026
 · 
5 min read
Press Releases
ProImmune Introduces Mastering Immunity 2026 - Shanghai Symposium to Address Key Immunogenicity Challenges
January 21, 2026
 · 
2 min read
Press Releases
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
January 21, 2026
 · 
5 min read
Press Releases
HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services
January 21, 2026
 · 
3 min read
Press Releases
Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
January 21, 2026
 · 
4 min read
Press Releases
Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1
January 20, 2026
 · 
7 min read
Press Releases
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
January 20, 2026
 · 
6 min read
Press Releases
Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development
January 20, 2026
 · 
4 min read
Press Releases
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders
January 20, 2026
 · 
6 min read
Press Releases
LexBio Named One of Ten “Honored Enterprises” in NVIDIA Inception Showcase 2025
January 19, 2026
 · 
1 min read
Press Releases
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene’s NouvNeu001, Making It the World’s First iPSC Therapy with Both FTD and RMAT Recognitions
January 19, 2026
 · 
5 min read
Press Releases
Akeso Announces NMPA Acceptance of Second NDA for Gumokimab (IL-17A Inhibitor) in Active Ankylosing Spondylitis
January 19, 2026
 · 
4 min read
Press Releases
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
January 19, 2026
 · 
10 min read
Press Releases
Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea
January 19, 2026
 · 
7 min read
Press Releases
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
January 19, 2026
 · 
2 min read
Press Releases
AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
January 19, 2026
 · 
3 min read
Press Releases
D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
January 19, 2026
 · 
3 min read
Load More